Compare Five Below Inc (FIVE) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five Below Inc vs Novo Nordisk A/S — how do they compare? Five Below Inc trades at $234.71 (market cap $12.95B), while Novo Nordisk A/S trades at $45.99 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 16.1× Five Below Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| FIVE | NVO | |
|---|---|---|
Market Cap | $12.95B | $207.85B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $63.98 |
52-Week Low | $134.36 | $35.29 |
Enterprise Value | $13.84B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
